Medtronic broadens its neurological product line
This article was originally published in Clinica
Executive Summary
Cardiology company Medtronic has acquired the world market leader in cerebrospinal fluid shunts, PS Medical, in a stock-swap at undisclosed terms. PS Medical will be integrated into Medtronic's neurological business and "play a major role as Medtronic targets diseases of the central nervous system", says Medtronic's CEO William George.